Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02128594 · ClinicalTrials.gov registry record · NA
Serosorting Intervention for HIV Negative MSM
A NA study, sponsored by University of Connecticut.
- Completed
- Registry status
- NA
- Development phase
- 600
- Enrollment target
NCT02128594 is a NA study that has completed, run by University of Connecticut. The registered enrollment target is 600 participants.
The verdict
NCT02128594, a NA study, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
Study Summary
Men who have sex with men make up a majority of incident HIV infections, however few effective interventions to prevent HIV transmission among this group exist. African American men who have sex with men (AAMSM) are disproportionately infected with STI/HIV and little is understood about how the role of stigma impacts their linkage and retention to health care during treatment. Effective strategies for reducing HIV related risk taking are urgently needed to prevent further spread of the HIV epidemic. The proposed research will test a behavioral intervention, which can be used during routine public health services, designed to reduce HIV risks posed by sexual partner selection strategies. The proposed research will also identify treatment barriers among MSM who test HIV/STI positive. Effective strategies for reducing social barriers to health care treatment rely on a comprehensive and thorough investigation into social barriers that affect AAMSM to effectively engage in medical care. These areas of research will be focused on for the current trial.
Interventions
- BEHAVIORAL Serosorting Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2012-01 |
| Est. Completion | 2015-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02128594
The ClinicalTrials.gov registry entry for NCT02128594 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Connecticut, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Serosorting Intervention is the first listed.
NCT02128594 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02128594 about?
NCT02128594 is a clinical study titled "Serosorting Intervention for HIV Negative MSM". Men who have sex with men make up a majority of incident HIV infections, however few effective interventions to prevent HIV transmission among this group exist. African American men who have sex with men (AAMSM) are disproportionately infected with STI/HIV and little is understood about how the role...
What is the current status of trial NCT02128594?
This trial is currently completed. It is a NA study. The enrollment target is 600 participants. The study started on 2012-01. Estimated completion is 2015-04.
What interventions are being tested in trial NCT02128594?
The interventions under investigation include: Serosorting Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02128594?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.